![HemaSphere Journal on Twitter: "M Domenica Cappellini discusses innovative treatments in #RareAnemias. Linked to her recent talk at #EHA2021, we are pleased to present her #HemaSphere article 👉https://t.co/OOp8Oke334 #OpenAccess #GeneEditing ... HemaSphere Journal on Twitter: "M Domenica Cappellini discusses innovative treatments in #RareAnemias. Linked to her recent talk at #EHA2021, we are pleased to present her #HemaSphere article 👉https://t.co/OOp8Oke334 #OpenAccess #GeneEditing ...](https://pbs.twimg.com/media/E36omTjX0AIjFpf.jpg)
HemaSphere Journal on Twitter: "M Domenica Cappellini discusses innovative treatments in #RareAnemias. Linked to her recent talk at #EHA2021, we are pleased to present her #HemaSphere article 👉https://t.co/OOp8Oke334 #OpenAccess #GeneEditing ...
![Talassemia, 30 anni di ricerca e cura raccontati dal Policlinico su The Lancet | News | Policlinico di Milano Talassemia, 30 anni di ricerca e cura raccontati dal Policlinico su The Lancet | News | Policlinico di Milano](https://i.ytimg.com/vi/aE5VbYWYAZc/maxresdefault.jpg)
Talassemia, 30 anni di ricerca e cura raccontati dal Policlinico su The Lancet | News | Policlinico di Milano
![Talassemie trasfusione dipendenti: cosa sono, quanto sono frequenti, come si arriva alla diagnosi - YouTube Talassemie trasfusione dipendenti: cosa sono, quanto sono frequenti, come si arriva alla diagnosi - YouTube](https://i.ytimg.com/vi/piu_Lt9FZmA/maxresdefault.jpg)
Talassemie trasfusione dipendenti: cosa sono, quanto sono frequenti, come si arriva alla diagnosi - YouTube
![YoungEHA on Twitter: "Panel discussion with @Russola and @IolasconL chaired by Prof. Maria Domenica Cappellini. A lot of questions and great answers! https://t.co/KdIiByWzft" / Twitter YoungEHA on Twitter: "Panel discussion with @Russola and @IolasconL chaired by Prof. Maria Domenica Cappellini. A lot of questions and great answers! https://t.co/KdIiByWzft" / Twitter](https://pbs.twimg.com/media/E36CoWCXMAEmzKp.jpg)